Our group has since shown that mismatch at HLA-DPB1 does not appear to impact GVHD incidence in 10/10 HLA-matched patients treated similarly to those in this study [55]; however, it is nonetheless a limitation that these loci were not considered in our analysis. The gene discussed is HLA-DPB1; the disease is graft versus host disease.